Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AZ And Ipsen Outline Brexit Contingency Plans

Executive Summary

With the UK no nearer to deciding how hard or soft its exit from the EU will be on March 29, AstraZeneca and Ipsen have given updates on their efforts to cope with the chaos that could ensue on the medicines supply front.

You may also be interested in...

No-Deal Brexit: More Fridges, No Drug Shortages, Says UK Gov't

As the UK parliament prepares for next week’s vote on the Brexit deal, the government is continuing with its contingency planning for a no-deal scenario, including the acquisition of refrigerated storage for stockpiled medicines.

Brexit: UK Gov’t Warns Against Medicines Stockpiling By NHS And Public

The UK government has issued guidance on actions the public health and care system in England should take to prepare for and cope with a potential “no deal” exit by the UK from the EU at the end of March next year. The government is also very clear on what it does not want providers such as hospitals and community pharmacies to do – stockpile medicines.

Ipsen CEO: 'I Assume a Hard Brexit', But Remain Bullish On UK Life Sciences

Ipsen's David Meek tells Scrip a Hard Brexit looks likely and that he's preparing the French pharma for that scenario.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts